Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Pricing  |   Participating on CanBiotech
Can Biotech - BioPharma Portal and B2B Marketplace Banner Description
Site Search:
    Home Open Innovation Engaged Thinking Patient Engagement Directory Events News Careers
 Event Advertisers   Show all: Event Advertisers


Click here to subscribe to Can Biotech Newsletters

 My Links   Show all: My Links

 CanBiotech News   Show all: CanBiotech News

 Investor: Alliances   Show all: Investor: Alliances


 Biopharma News in Asia   Show all: Biopharma News in Asia


 Innovation Blogs and News   Show all: Innovation Blogs and News
 
A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.

 
Engaging patients for drug repurposing: Mapping the patient engagement continuum
November 2015
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.
Patient Research Priorities
October 2015
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers.
Read More...

P
atient Engagment/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Read More...

Listening to Patients
September 2015

In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Read More...

Fostering Behavior Change for Better Health

Using design thinking, researchers developed five distinct patient segments and created journey maps to chart the experiences of patients from each of these segments from diagnosis to long-term treatment adherence in the context of HIV management.
Read More...

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
September 2015

The collaboration will pair Sanofi’s leadership in diabetes treatments and devices with Google’s expertise in analytics, miniaturized electronics and low power chip design. The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.

Read More...

The Lilly COI API and TrialReach: A Story of Innovation
August 2015

A vision for inclusive and participatory clinical knowledge generation, with particpation by all including patients in the clinical research ecosystem. Participatory is at the core of open innovation at Lilly.
Read More...

Patient Engagement and Cultural Competence
July 2015

Should the pharmaceutical industry consider cultural competence a driver for more holistic patient engagement? Care providers and health care organizations are seeking to align patient engagement and cultural competency to better understand disease management and compliance issues.
Read More...

Pfizer's Global Innovation Network
June 2015

In this webinar, Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions”.
Read More...

An Interview with Novartis
June 2015

In this interview, the CEO of Swiss pharmaceutical company Novartis, Joseph Jimenez, discusses how digitization is driving innovation, and why Novartis is shifting to an outcomes-based approach for patient treatments.
Read More...


Pharma Behind Other Industries in Customer Engagement

Expanded Patient Role
June 2015

Patient engagement can be traced across the drug-development pipeline including the impact of recent policy initiatives, and prospects moving forward.
Read More...


Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement
It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design.
Read More:
http://informahealthcare.com/doi/abs/10.1517/17460441.2015.1037271

Continuing Reading More Innovation News and Blogs...


Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2016 CanBiotech™ Inc.